Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus

This publication has 17 references indexed in Scilit:

• Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination
  Veterinary Immunology and Immunopathology, 2006
• Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection
  Vaccine, 2006
• Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1
  Vaccine, 2005
• Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination
  Veterinary Immunology and Immunopathology, 2004
• Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
  Proceedings of the National Academy of Sciences, 1996
• Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines
  Veterinary Record, 1994
• The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA
  Veterinary Record, 1993
• Duration of circulating antibody and immunity following infection with equine influenza virus
  Veterinary Record, 1988
• Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.
  The Journal of Experimental Medicine, 1987
• Studies with inactivated equine influenza vaccine: 1. Serological responses of ponies to graded doses of vaccine
  Epidemiology and Infection, 1983